Question 1

What is "Screening of Investigational Therapeutics to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)"?

Accepted Answer

### PROCUREMENT OVERVIEW
The National Institutes of Health (NIH) is seeking proposals for the screening of investigational therapeutics aimed at treating, modifying, or preventing epilepsy. This initiative is part of the Epilepsy Therapy Screening Program (ETSP) and is designed to fulfill the core need for effective therapeutic solutions in the management of epilepsy. The project scope includes identifying and evaluating potential therapeutic candidates through rigorous screening processes, ultimately contributing to advancements in epilepsy treatment.

### ISSUING ORGANIZATION
The issuing organization is the Department of Health and Human Services, specifically the National Institutes of Health (NIH), located in Maryland, USA. The primary contact for this opportunity is Rieka N. Plugge, who can be reached via email at rieka.plugge@nih.gov.

### KEY DATES
- **Posted Date:** March 24, 2026
- **Proposal Due Date:** April 7, 2026
- **Anticipated Award Date:** Not specified
- **Performance Period:** Not specified

### CONTRACT DETAILS
The contract type is not explicitly stated in the provided information. Additionally, there is no mention of an estimated contract value or budget range, nor are there any details regarding option years.

### MANDATORY REQUIREMENTS
To be eligible for consideration, bidders must meet the following mandatory requirements:
- **Certifications and Registrations:** Registration in SAM.gov is required.
- **Security Clearances:** No specific security clearances are mentioned.
- **Set-Aside Restrictions:** There are no specific set-aside restrictions noted.
- **Geographic Restrictions:** No geographic restrictions or place-of-performance requirements are specified.
- **Experience Requirements:** Minimum years of experience or past performance requirements are not detailed.
- **Bonding or Insurance Requirements:** No bonding or insurance requirements are mentioned.

### TECHNICAL CAPABILITIES
Bidders must possess specific technical skills related to the screening of therapeutics for epilepsy. While the exact methodologies, technologies, or tools are not detailed, expertise in pharmacology, clinical trials, and therapeutic development is implied as essential for the successful execution of the project.

### DELIVERABLES AND PERFORMANCE STANDARDS
Key deliverables and performance standards are not explicitly outlined in the provided information. Bidders should anticipate that deliverables will likely include screening reports, data analysis, and progress updates, although specific milestones and reporting requirements are not detailed.

### EVALUATION CRITERIA
The evaluation criteria for proposals have not been explicitly stated. However, bidders should prepare to demonstrate their technical approach, past performance, and pricing strategies, as these are typically critical factors in government procurement evaluations.

### PREFERRED QUALIFICATIONS
While not mandatory, preferred qualifications that could enhance a bidder's competitiveness may include:
- Experience in conducting clinical trials or therapeutic screenings.
- Advanced certifications in relevant fields (e.g., clinical research, pharmacology).
- Proven track record in epilepsy research or related therapeutic areas.

This summary provides a comprehensive overview of the opportunity, highlighting essential information for bidders to assess their fit for the project.

Question 2

When is the proposal submission deadline?

Accepted Answer

The proposal submission deadline is April 7, 2026 (4 days left).

Question 3

What NAICS codes apply to this opportunity?

Accepted Answer

The applicable NAICS codes are: 541715.

Question 4

Are there any set-aside requirements?

Accepted Answer

Yes, this opportunity includes the following set-asides: NONE.

Question 5

Where can I submit a proposal or get solicitation documents?

Accepted Answer

You can access the full solicitation documents and submit your proposal at: https://sam.gov/workspace/contract/opp/ee43960bb7024a298c8890bd6eab245b/view

Screening of Investigational Therapeutics to Treat, Modify or Prevent Epilepsy for the NINDS Epilepsy Therapy Screening Program (ETSP)

Actions

Documents

Additional Information

Source

Source Record ID

Source URL

Type

Status

Is Public

Contract Type

Deadline Text

Created

Last Updated

Contact Info Name

Contact Info Email

Regions Of Opportunity

Organization Address Province

Organization Address Postal Code

Organization Country

Reference Number

Amendment Number

Summary Updated At

Frequently Asked Questions

Additional Details

NAICS Codes

Set-Asides

AI Summary

Explore More Opportunities